APA (7th ed.) Citation

Matikainen, N., & Taskinen, M. (2013). The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with Type 2 diabetes. Diabetic Medicine, 30(6), 756. https://doi.org/10.1111/dme.12094

Chicago Style (17th ed.) Citation

Matikainen, N., and M.‐R Taskinen. "The Effect of Vildagliptin Therapy on Atherogenic Postprandial Remnant Particles and LDL Particle Size in Subjects with Type 2 Diabetes." Diabetic Medicine 30, no. 6 (2013): 756. https://doi.org/10.1111/dme.12094.

MLA (9th ed.) Citation

Matikainen, N., and M.‐R Taskinen. "The Effect of Vildagliptin Therapy on Atherogenic Postprandial Remnant Particles and LDL Particle Size in Subjects with Type 2 Diabetes." Diabetic Medicine, vol. 30, no. 6, 2013, p. 756, https://doi.org/10.1111/dme.12094.